Heparin prevents oxidative stress-induced apoptosis in human decidualized endometrial stromal cells

Rai R, Cohen H, Dave M, Regan L (1997) Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314:253–257

Rai R, Regan L (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100:1354

Sebire NJ, Backos M, El Gaddal G, Goldin RD, Regan L (2003) Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol 101:258–263

Urman B, Ata B, Yakin K, Alatas C, Aksoy S, Mercan R, Balaban B (2009) Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. Hum Reprod 24:1640–1647

Qublan H, Amarin Z, Dabbas M, Farraj AE, Beni-Merei Z, Al-Akash H, Bdoor AN, Nawasreh M, Malkawi S, Diab F, Al-Ahmad N, Balawneh M, Abu-Salim A (2008) Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum Fertil (Camb) 11:246–253

Hills FA, Abrahams VM, Gonzalez-Timon B, Franvis J, Clock B, Hinkson L, Rai R, Mor Regan L, Sullivan M, Lam EW, Brosens JJ (2006) Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod 12:237–243

Fluhr H, Spratte J, Ehrardt J, Steinmuller F, Licht P, Zygmunt M (2010) Heparin and low-molecular-weight heparins modulate the decidualization of human endometrial stromal cells. Fertil Steril 93:2581–2587

Kajihara T, Jones M, Fusi L, Takano M, Feroze-Zaidi F, Pirianov G, Mehmet H, Ishihara O, Higham JM, Lam EW, Brosens JJ (2006) Differetial expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization. Mol Endocrinol 20:2444–2455

Kajihara T, Uchino S, Suzuki M, Itakura A, Brosens JJ, Ishihara O (2011) Human chorionic gonadotropin confers resistance to oxidative stress-induced apoptosis in decidualizing human endometrial stromal cells. Fertil Steril 95:1302–1307

Labied S, Kajihara T, Madureira PA, Fusi L, Jones MC, Higham JM, Varshochi R, Francis JM, Zoumpoulidou G, Essafi A, Fernandez de Mattos S. Lam EW, Brosens JJ (2006) Pregestins regulate the expression and activity of the forkhead transcription factor FOXO1 in differentiating human endometrium. Mol Endocrinol 20:35–44

Brosens JJ, Hayashi N, White JO (1999) Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cell. Endocrinology 140:4809–4820

Christian M, Zhang X, Schneider-Merck T, Unterman TG, Gellersen B, White JO, Brosens JJ (2002) Cyclic AMP-induced forkhead transcription factor, FKHR, cooperates with CCAAT/enhancer-binding protein b in differentiating human endometrial stromal cells. J Biol Chem 277:20825–20832

Tochigi H, Kajihara T, Mizuno Y, Mizuno Y, Tamaru S, Kamei Y, Okazaki Y, Brosens JJ, Ishihara O (2017) Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells. Sci Rep 2017:40001

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods 25:402–408

Gellersen B, Kempf R, Telgmann R, DiMattia GE (1994) Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lyphocytes and in endometrial stroma. Mol Endocrinol 8:356–373

Gellersen B, Brosens J (2003) Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J Endocrinol 178:357–372

Kajihara T, Brosens JJ, Ishihara O (2013) The role of FOXO1 in the decidual transformation of the endometrium and early pregnancy. Med Mol Morphol 46:61–68

Steptoe PC, Edwards RG (1978) Birth after the reimplantation of a human embryo. Lancet 2(8085):366

Donaghay M, Lessey BA (2007) Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med 25:461–475

Gellersen B, Brosens IA, Brosens JJ (2007) Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med 25:445–453

Wilcox AJ, Baird DD, Weinberg CR (1999) Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 340:1796–1799

Ricci G, Giolo E, Simeone R (2010) Heparin’s `potential to improve pregnancy rates and outcomes’ is not evidence-based. Hum Reprod Update 16:225–227

Cloke B, Huhtinen K, Fusi L, Kajihara T, Yliheikkila M, Ho KK, Teklenburg G, Lavery S, Jones MC, Trew G, Kim JJ, Lam EW, Cartwright JE, Poutanen M, Brosens JJ (2008) The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium. Endocrinolgy 149:4462–4474

Lynch VJ, Tanzer A, Wang Y, Leung FC, Gellersen B, Emera D, Wagner GP (2008) Adaptive changes in the transcription factor HoxA–11 are essential for the evolution of pregnancy in mammals. Proc Natl Acad Sci USA 105:14928–14933

Fluhr H, Spratte J, Heidrich S, Ehrhardt J, Steinmüller F, Zygmunt M (2011) Heparin inhibits interferon-γ signaling in human endometrial stromal cells by interference with the cellular binding of interferon-γ. Fertil Steril 95:1272–1277

Salker M, Teklenburg G, Molokhia M, Lavery S, Trew G, Aojanepong T, Mardon H, Lokugamage AU, Rai R, Landles C, Roelen BA, Quenby S, Kuijk EW, Kavelaars A, Heijnen CJ, Regan L, Macklon NS, Brosens JJ (2010) Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. PLoS One 5:e10287

Garzia E, Borgato S, Cozzi V, Doi P, Bulfamante G, Persani L, Cetin I (2004) Lack of expression of endometrial prolactin in early implantation failure: a pilot study. Hum Reprod 19:1911–1916

Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ (2000) Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 157:2111–2122

Jauniaux E, Poston L, Burton GJ (2006) Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 12:747–755

Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM (1999) Direct control of the forkhead transcription factor AFX by protein kinase B. Nature 398:630–634

Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868

Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW, Burgering BM, Raaijmakers JA, Lammers JW, Koenderman L, Coffer PJ (2000) Forkhead transcription factor FKHR-1 modulates cytokine-dependent transcriptional regulation of p27KIP1. Mol Cell Biol 20:9138–9148

Sunters A, Fernandez de Mottos S, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA, Coffer PJ, Medema RH, Coombes RC, Lam EW (2003) FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 278:49795–49805

Modur V, Nagarajan R, Evers BM, Milbrandt J (2002) FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem 277:47928–47937

Suhara T, Kim HS, Kirshenbaum LA, Walsh K (2002) Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation. Mol Cell Biol 22:680–691

Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ (2000) Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10:1201–1204

Medema RH, Kops GJ, Bos JL, Burgering BM (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:782–787

Nemoto S, Finkel T (2002) Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295:2450–2452

Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL, Burgering BM, EMBO J (2004) FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 23:4802–4812

Tran H, Brunet A, Grenier JM, Datta SR, Fornace AJ Jr, DiStefano PS, Chiang LW, Greenberg ME (2002) DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296:530–534

Di Simone N, Di Niculo F, Sanguinetti M, Ferrazzani S, D’Alessio MC, Castellani R, Bompiani A, Caruso A (2007) Low-molecular weight heparin induces in vitro trophoblast invasiveness: role matrix metalloproteinases and tissue inhibitors. Placenta 28:298–304

Greer I, Hunt BJ (2005) Low molecular weight heparin in pregnancy: current issues. Br J Haematol 128:593–601

Kutteh WH (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174:1584–1589

Spratte J, Schönborn M, Treder N, Bornkessel F, Zygmunt M, Fluhr H (2015) Heparin modulates chemokines in human endometrial stromal cells by interaction with tumor necrosis factor α and thrombin. Fertil Steril 103:1363–1369

Yamamoto H, Fuyama S, Arai S, Sendo F (1985) Inhibition of mouse natural killer cytotoxicity by heparin. Cell Immunol 96:409–417

Johann S, Zoller C, Haas S, Blumel G, Lipp M, Forster R (1995) Sulfated polysaccharide anticoagulants suppress natural killer cell activity in vitro. Thromb Haemost 74:998–1002

Christopherson KW 2nd, Campbell JJ, Travers JB, Hromas RA (2002) Low-molecular-weight heparins inhibit CCL2l-induced T cell adhesion and migration. J Pharmacol Exp Ther 302:290–295

Manduteanu I, Voinea M, Capraru M, Dragomir E, Simionescu M (2002) A novel attribute of enoxaparin: inhibition of monocyte adhesion to endothelial cells by a mechanism involving cell adhesion molecules. Pharmacology 65:52–53

Wan JG, Mu JS, Zhu HS, Geng JG (2002) N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury in vitro. Inflamm Res 51:435–443

Fritchley SJ, Kirby JA, Ali S (2000) The antagonism of interferon-gamma (INF-gamma) by heparin: examination of the blockade of class II MHC antigen and heat shock protein-70 expression. Clin Exp Med Biol 120:247–252

Folkman J, Shing Y (1992) Control of angiogenesis by heparin and other sulfated polysaccharides. Adv Exp Med Biol 313:355–364

Li Y, Wang HY, Cho CH (1999) Association of heparin with basic fibroblast growth factor, epidermal growth factor, and constitutive nitric oxide synthase on healing of gastric ulcer in rats. J Pharmacol Exp Ther 290:789–796